17289346|t|Cellular demise and inflammatory microglial activation during beta-amyloid toxicity are governed by Wnt1 and canonical signaling pathways.
17289346|a|Initially described as a modulator of embryogenesis for a number of organ systems, Wnt1 has recently been linked to the development of several neurodegenerative disorders, none being of greater significance than Alzheimer's disease. We therefore examined the ability of Wnt1 to oversee vital pathways responsible for cell survival during beta-amyloid (Abeta1-42) exposure. Here we show that Wnt1 is critical for protection in the SH-SY5Y neuronal cell line against genomic DNA degradation, membrane phosphatidylserine (PS) exposure, and microglial activation, since these neuroprotective attributes of Wnt1 are lost during gene silencing of Wnt1 protein expression. Intimately tied to Wnt1 protection is the presence and activation of Akt1. Pharmacological inhibition of the PI 3-K pathway or gene silencing of Akt1 expression can abrogate the protective capacity of Wnt1. Closely aligned with Wnt1 and Akt1 are the integrated canonical pathways of synthase kinase-3beta (GSK-3beta) and beta-catenin. Through Akt1 dependent pathways, Wnt1 phosphorylates GSK-3beta and maintains beta-catenin integrity to insure its translocation from the cytoplasm to the nucleus to block apoptosis. Our work outlines a highly novel role for Wnt1 and its integration with Akt1, GSK-3beta, and beta-catenin to foster neuronal cell survival and repress inflammatory microglial activation that can identify new avenues of therapy against neurodegenerative disorders.
17289346	20	32	inflammatory	Disease	MESH:D007249
17289346	100	104	Wnt1	Gene	7471
17289346	222	226	Wnt1	Gene	7471
17289346	282	309	neurodegenerative disorders	Disease	MESH:D019636
17289346	351	370	Alzheimer's disease	Disease	MESH:D000544
17289346	409	413	Wnt1	Gene	7471
17289346	530	534	Wnt1	Gene	7471
17289346	569	576	SH-SY5Y	CellLine	CVCL:0019
17289346	638	656	phosphatidylserine	Chemical	MESH:D010718
17289346	658	660	PS	Chemical	MESH:D010718
17289346	741	745	Wnt1	Gene	7471
17289346	780	784	Wnt1	Gene	7471
17289346	824	828	Wnt1	Gene	7471
17289346	874	878	Akt1	Gene	207
17289346	950	954	Akt1	Gene	207
17289346	1006	1010	Wnt1	Gene	7471
17289346	1033	1037	Wnt1	Gene	7471
17289346	1042	1046	Akt1	Gene	207
17289346	1111	1120	GSK-3beta	Gene	2932
17289346	1126	1138	beta-catenin	Gene	1499
17289346	1148	1152	Akt1	Gene	207
17289346	1173	1177	Wnt1	Gene	7471
17289346	1193	1202	GSK-3beta	Gene	2932
17289346	1217	1229	beta-catenin	Gene	1499
17289346	1364	1368	Wnt1	Gene	7471
17289346	1394	1398	Akt1	Gene	207
17289346	1400	1409	GSK-3beta	Gene	2932
17289346	1415	1427	beta-catenin	Gene	1499
17289346	1473	1485	inflammatory	Disease	MESH:D007249
17289346	1557	1584	neurodegenerative disorders	Disease	MESH:D019636
17289346	Association	MESH:D019636	7471
17289346	Negative_Correlation	MESH:D007249	7471
17289346	Association	2932	7471
17289346	Association	207	2932
17289346	Association	MESH:D019636	1499
17289346	Association	MESH:D007249	207
17289346	Association	MESH:D007249	1499
17289346	Association	MESH:D010718	7471
17289346	Association	MESH:D007249	2932
17289346	Association	1499	7471
17289346	Association	207	7471
17289346	Association	MESH:D019636	2932
17289346	Association	1499	207

